Department of Morphology, Surgery and Experimental Medicine, Section of General Pathology, Interdisciplinary Center for the Study of Inflammation, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Via Borsari 46, Ferrara, Italy.
Oxid Med Cell Longev. 2013;2013:564961. doi: 10.1155/2013/564961. Epub 2013 Mar 27.
Reactive oxygen species (ROS) are a byproduct of the normal metabolism of oxygen and have important roles in cell signalling and homeostasis. An imbalance between ROS production and the cellular antioxidant defence system leads to oxidative stress. Environmental factors and genetic interactions play key roles in oxidative stress mediated pathologies. In this paper, we focus on cardiovascular diseases and obesity, disorders strongly related to each other; in which oxidative stress plays a fundamental role. We provide evidence of the key role played by p66(Shc) protein and protein kinase C (PKC) in these pathologies by their intracellular regulation of redox balance and oxidative stress levels. Additionally, we discuss possible therapeutic strategies aimed at attenuating the oxidative damage in these diseases.
活性氧(ROS)是氧正常代谢的副产物,在细胞信号转导和内稳态中具有重要作用。ROS 产生与细胞抗氧化防御系统之间的失衡会导致氧化应激。环境因素和遗传相互作用在氧化应激介导的病理中起着关键作用。在本文中,我们重点关注心血管疾病和肥胖症,这两种疾病密切相关,氧化应激在其中起着根本性的作用。我们提供了证据表明,p66(Shc)蛋白和蛋白激酶 C(PKC)通过其对氧化还原平衡和氧化应激水平的细胞内调节,在这些疾病中发挥关键作用。此外,我们还讨论了旨在减轻这些疾病中氧化损伤的可能治疗策略。